LFWD Logo

Lifeward Ltd. (LFWD) Stock Forecast & Price Prediction

Live LFWD Stock Price & Analysis

Home โ€บ Stocks โ€บ Israel | NASDAQ | Healthcare | Medical Devices

$2.19

+0.22 (10.91%)

12 Month Price Forecast For LFWD

$2.19
Current Price
$23.22M
Market Cap
3 Ratings
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to LFWD Price Forecasts

+495.0%
To High Target of $13.00
+357.7%
To Median Target of $10.00
+174.6%
To Low Target of $6.00

LFWD Price Momentum

+55.7%
1 Week Change
+20.4%
1 Month Change
-65.9%
1 Year Change
+26.0%
Year-to-Date Change
-71.6%
From 52W High of $7.70
+74.8%
From 52W Low of $1.25

๐Ÿค” Considering ReWalk (LFWD)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 16, 2025 4:48 AM UTC

LFWD Analyst Ratings & Price Targets

Based on our analysis of 3 Wall Street analysts, LFWD has a bullish consensus with a median price target of $10.00 (ranging from $6.00 to $13.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $2.19, the median forecast implies a 357.7% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Swayampakula Ramakanth at HC Wainwright & Co., projecting a 495.0% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

LFWD Analyst Consensus

3
Buy
0
Hold
0
Sell

LFWD Price Target Range

Low
$6.00
Average
$10.00
High
$13.00
Current: $2.19

Latest LFWD Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for LFWD.

Date Firm Analyst Rating Change Price Target
Feb 10, 2025 Laidlaw & Co. Yale Jen Buy Initiates $10.00
Nov 13, 2024 HC Wainwright & Co. Swayampakula Ramakanth Buy Reiterates $13.00
Aug 16, 2024 HC Wainwright & Co. Swayampakula Ramakanth Buy Maintains $13.00
May 16, 2024 HC Wainwright & Co. Swayampakula Ramakanth Buy Maintains $13.00
Apr 15, 2024 HC Wainwright & Co. Swayampakula Ramakanth Buy Reiterates $9.00
Feb 28, 2024 HC Wainwright & Co. Swayampakula Ramakanth Buy Reiterates $3.00
Nov 15, 2023 HC Wainwright & Co. Buy Reiterates $0.00
Aug 14, 2023 HC Wainwright & Co. Buy Reiterates $0.00
Aug 10, 2023 HC Wainwright & Co. Buy Reiterates $0.00
Jul 3, 2023 HC Wainwright & Co. Buy Reiterates $0.00
May 12, 2023 HC Wainwright & Co. Buy Reiterates $0.00
Feb 24, 2023 HC Wainwright & Co. Buy Reiterates $0.00
Nov 15, 2022 HC Wainwright & Co. Buy Maintains $0.00
Aug 10, 2022 HC Wainwright & Co. Buy Maintains $0.00
Mar 1, 2021 HC Wainwright & Co. Buy Maintains $0.00
Aug 13, 2020 HC Wainwright & Co. Buy Maintains $0.00
Feb 21, 2020 HC Wainwright & Co. Buy Reiterates $0.00
Jun 17, 2019 HC Wainwright & Co. Buy Upgrade $0.00
Nov 3, 2017 Jefferies Buy Maintains $0.00
Aug 4, 2017 Canaccord Genuity Buy Maintains $0.00

Stocks Similar to Lifeward Ltd.

The following stocks are similar to ReWalk based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Lifeward Ltd. (LFWD) Financial Data

Lifeward Ltd. has a market capitalization of $23.22M with a P/E ratio of -0.8x. The company generates $25.00M in trailing twelve-month revenue with a -77.2% profit margin.

Revenue growth is +39.2% quarter-over-quarter, while maintaining an operating margin of -51.8% and return on equity of -45.1%.

Valuation Metrics

Market Cap $23.22M
Enterprise Value $7.68M
P/E Ratio -0.8x
PEG Ratio -2.3x
Price/Sales 0.9x

Growth & Margins

Revenue Growth (YoY) +39.2%
Gross Margin +36.2%
Operating Margin -51.8%
Net Margin -77.2%
EPS Growth N/A

Financial Health

Cash/Price Ratio +55.3%
Current Ratio 2.7x
Debt/Equity 2.9x
ROE -45.1%
ROA -18.9%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Lifeward Ltd. logo

Lifeward Ltd. (LFWD) Company Overview

About Lifeward Ltd.

What They Do

Develops medical devices for rehabilitation and mobility.

Business Model

Lifeward Ltd. generates revenue by designing, developing, and selling innovative medical devices aimed at improving mobility and wellness for individuals with physical and neurological conditions. The company markets its products directly to healthcare institutions and individuals, as well as through third-party distributors, ensuring a wide reach in both rehabilitation and personal use markets.

Additional Information

The company's product lineup includes advanced technologies such as the ReWalk exoskeletons and the AlterG Anti-Gravity System, catering to various rehabilitation needs. Lifeward Ltd. was formerly known as ReWalk Robotics Ltd. and has been incorporated since 2001, with its headquarters located in Yokneam Illit, Israel.

Company Information

Sector

Healthcare

Industry

Medical Devices

Employees

108

CEO

Mr. Lawrence J. Jasinski BS, MBA

Country

Israel

IPO Year

2014

Lifeward Ltd. (LFWD) Latest News & Analysis

LFWD stock latest news image
Quick Summary

The Company has secured recent financing and believes it has adequate cash to achieve its objectives.

Why It Matters

The company's strong cash position indicates financial stability and the ability to execute growth plans, potentially enhancing shareholder value and attracting investor interest.

Source: GlobeNewsWire
Market Sentiment: Neutral
LFWD stock latest news image
Quick Summary

Lifeward Ltd. (Nasdaq: LFWD) has canceled its Extraordinary General Meeting scheduled for January 13, 2025, and will present its proposals at a later meeting in 2025.

Why It Matters

Cancellation of the shareholder meeting may indicate uncertainty or internal issues within Lifeward, potentially affecting stock performance and investor confidence.

Source: GlobeNewsWire
Market Sentiment: Neutral
LFWD stock latest news image
Quick Summary

Lifeward Ltd. (Nasdaq: LFWD) will issue 1,818,183 ordinary shares at $2.75 each in a registered direct offering, along with short-term warrants. Closing expected on January 8, 2025.

Why It Matters

Lifeward Ltd. is raising capital through a direct offering and warrants, potentially impacting share dilution and investor sentiment around its growth prospects.

Source: GlobeNewsWire
Market Sentiment: Neutral
LFWD stock latest news image
Quick Summary

Lifeward Ltd. (Nasdaq: LFWD) closed a registered direct offering of 1.82 million shares at $2.75 each, along with unregistered short-term warrants for the same number of shares.

Why It Matters

Lifeward's capital raise via share offering and warrants can signal growth potential but may dilute existing shares. Investors should assess the impact on share value and company strategy.

Source: GlobeNewsWire
Market Sentiment: Neutral
LFWD stock latest news image
Quick Summary

Lifeward Ltd. has postponed its Extraordinary General Meeting of Shareholders to January 13, 2025. The record date remains November 20, 2024.

Why It Matters

The postponement of Lifeward's shareholder meeting may signal potential uncertainty or issues within the company, impacting investor confidence and stock performance.

Source: GlobeNewsWire
Market Sentiment: Neutral
LFWD stock latest news image
Quick Summary

Semmelweis University in Hungary has secured government coverage for exoskeleton training, increasing access at more spinal cord injury centers.

Why It Matters

Government coverage for exoskeleton training can boost demand in the healthcare sector, potentially increasing revenues for companies involved in rehabilitation technologies and attracting investment.

Source: GlobeNewsWire
Market Sentiment: Neutral

Frequently Asked Questions About LFWD Stock

What is Lifeward Ltd.'s (LFWD) stock forecast for 2025?

Based on our analysis of 3 Wall Street analysts, Lifeward Ltd. (LFWD) has a median price target of $10.00. The highest price target is $13.00 and the lowest is $6.00.

Is LFWD stock a good investment in 2025?

According to current analyst ratings, LFWD has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.19. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for LFWD stock?

Wall Street analysts predict LFWD stock could reach $10.00 in the next 12 months. This represents a 357.7% increase from the current price of $2.19. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Lifeward Ltd.'s business model?

Lifeward Ltd. generates revenue by designing, developing, and selling innovative medical devices aimed at improving mobility and wellness for individuals with physical and neurological conditions. The company markets its products directly to healthcare institutions and individuals, as well as through third-party distributors, ensuring a wide reach in both rehabilitation and personal use markets.

What is the highest forecasted price for LFWD Lifeward Ltd.?

The highest price target for LFWD is $13.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 495.0% increase from the current price of $2.19.

What is the lowest forecasted price for LFWD Lifeward Ltd.?

The lowest price target for LFWD is $6.00 from at , which represents a 174.6% increase from the current price of $2.19.

What is the overall LFWD consensus from analysts for Lifeward Ltd.?

The overall analyst consensus for LFWD is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $10.00.

How accurate are LFWD stock price projections?

Stock price projections, including those for Lifeward Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.